Use of a recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) 2:1 combination for controlled ovarian stimulation during assisted reproductive technology treatment: A real-world study of routine practice in the Russian Federation

Two observational studies in the Russian Federation described patient demographics/clinical decision for treatment with recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) 2:1 combination for ovarian stimulation (OS) during assisted reproductive techno...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY 2022-12, Vol.85 (Pt B), p.134-148
Hauptverfasser:	Koloda, Yulia, Korsak, Vladislav, Rozenson, Oleg, Anshina, Margarita, Sagamonova, Karina, Baranov, Igor, Yakovenko, Sergey, D'Hooghe, Thomas, Ershova, Anna, Lispi, Monica
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!